Evidence map›Paper›PMID 41285107›Full record

ArticlePhysics in medicine and biology2026

GATE 10 Monte Carlo particle transport simulation: I. Development and new features.

David Sarrut, Nicolas Arbor, Thomas Baudier, Julien Bert, Konstantinos Chatzipapas, Martina Favaretto, Hermann Fuchs, Loïc Grevillot, Hussein Harb, Gert Van Hoey and 23 more

Abstract read
In one paragraph

Article in Physics in medicine and biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors.

David SarrutUniversité de Lyon; CREATIS; CNRS UMR5220; Inserm U1294; INSA-Lyon; Université Lyon 1, Lyon, France.ORCID 0000-0002-4854-4141
Nicolas ArborUniversité de Strasbourg, IPHC, CNRS, UMR7178, F-67037 Strasbourg, France.ORCID 0000-0001-6457-1767
Thomas BaudierUniversité de Lyon; CREATIS; CNRS UMR5220; Inserm U1294; INSA-Lyon; Université Lyon 1, Lyon, France.
Julien BertLaTIM, INSERM UMR1101, University of Brest, Brest, France.ORCID 0000-0002-2756-942X
Konstantinos ChatzipapasLaTIM, INSERM UMR1101, University of Brest, Brest, France.ORCID 0000-0003-4006-9304
Martina FavarettoMedAustron Ion Therapy Center, Wiener Neustadt, Austria.ORCID 0009-0000-7899-3952
Hermann FuchsDepartment of Radiation Oncology, Medical University of Vienna, Vienna, Austria.ORCID 0000-0001-9003-5730
Loïc GrevillotMedAustron Ion Therapy Center, Wiener Neustadt, Austria.ORCID 0000-0003-3433-9582
Hussein HarbLaTIM, INSERM UMR1101, University of Brest, Brest, France.ORCID 0009-0004-9615-6831
Gert Van HoeyXEOS, Ghent, Belgium.
Maxime JacquetUniversité de Lyon; CREATIS; CNRS UMR5220; Inserm U1294; INSA-Lyon; Université Lyon 1, Lyon, France.ORCID 0000-0002-5665-704X
Sébastien JanUniversité Paris-Saclay, Inserm, CNRS, CEA, Laboratoire d'Imagerie Biomédicale Multimodale (BioMaps), Orsay, France.
Yihan JiaMedAustron Ion Therapy Center, Wiener Neustadt, Austria.ORCID 0000-0001-8411-0036
George C Kagadis3DMI Research Group, Department of Medical Physics, University of Patras, Rion, Greece.ORCID 0000-0002-6983-2863
Han Gyu KangNational Institutes for Quantum Science and Technology (QST), 4-9-1 Anagawa, Inage-ku, Chiba, Japan.ORCID 0000-0001-5338-4819
Paul KleverFH Aachen University of Applied Sciences, Aachen, Germany.
Olga KochebinaUniversité Paris-Saclay, Inserm, CNRS, CEA, Laboratoire d'Imagerie Biomédicale Multimodale (BioMaps), Orsay, France.ORCID 0000-0003-4119-4465
Wojciech KrzemienHigh Energy Physics Division, National Centre for Nuclear Research, Andrzeja Soltana 7, Otwock, Swierk PL-05-400, Poland.
Lydia MaigneUniversité Clermont Auvergne, Laboratoire de Physique de Clermont Auvergne, CNRS, Clermont-Ferrand, France.ORCID 0000-0002-0414-8462
Philipp MohrUniversity of Groningen, University Medical Center Groningen, Groningen, The Netherlands.ORCID 0000-0001-9391-3287
Guneet MummaneniUniversity of California, Davis, Davis, CA, United States of America.ORCID 0009-0006-5745-7249
Valentina PanetaBioemission Technology Solutions, BIOEMTECH, Athens, Greece.ORCID 0000-0002-9485-8993
Panagiotis PapadimitroulasBioemission Technology Solutions, BIOEMTECH, Athens, Greece.ORCID 0000-0002-5981-6149
Alexis PeredaUniversité Clermont Auvergne, Laboratoire de Physique de Clermont Auvergne, CNRS, Clermont-Ferrand, France.ORCID 0000-0002-1434-8230
Axel RannouLaTIM, INSERM UMR1101, University of Brest, Brest, France.ORCID 0009-0002-9963-0020
Andreas F ReschMedAustron Ion Therapy Center, Wiener Neustadt, Austria.ORCID 0000-0002-6728-455X
Emilie RoncaliUniversity of California, Davis, Davis, CA, United States of America.ORCID 0000-0002-2439-1064
Maxime ToussaintLaboratoire CRCI2NA, INSERM, CNRS, Nantes Université, Nantes, France.ORCID 0000-0003-3402-8186
Carlotta TrigilaUniversity of California, Davis, Davis, CA, United States of America.ORCID 0000-0002-0414-9369
Charalampos TsoumpasUniversity of Groningen, University Medical Center Groningen, Groningen, The Netherlands.ORCID 0000-0002-4971-2477
Jing ZhangLaTIM, INSERM UMR1101, University of Brest, Brest, France.ORCID 0000-0001-5471-3418
Karl ZiemonsFH Aachen University of Applied Sciences, Aachen, Germany.ORCID 0000-0001-5744-7290
Nils KrahUniversité de Lyon; CREATIS; CNRS UMR5220; Inserm U1294; INSA-Lyon; Université Lyon 1, Lyon, France.ORCID 0000-0002-1376-6633

Funding

AI-accelerated optical simulation for fast timing nuclear imagingR01EB034475 · NIBIB · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Emilie Roncali · 2023 to 2026
$2.4M
NIBIB NIH HHS R01 EB034475
6 · The paper itself

Abstract

We present GATE version 10, a major evolution of the open-source Monte Carlo simulation application for medical physics, built on Geant4. This release marks a transformative evolution, featuring a modern Python-based user interface, enhanced multithreading and multiprocessing capabilities, the ability to be embedded as a library within other software, and a streamlined framework for collaborative development. In this Part 1 paper, we outline GATE's position among other Monte Carlo codes, the core principles driving this evolution, and the robust development cycle employed. We also detail the new features and improvements. Part 2 will focus on the architectural innovations and technical challenges. By combining an open, collaborative framework with cutting-edge features, such a Monte Carlo platform supports a wide range of academic and industrial research, solidifying its role as a critical tool for innovation in medical physics.

Indexed as

Monte Carlo MethodSoftwaredose calculation in radiation therapyMonte Carlo simulationnuclear imagingscientific software

Identifiers

PMID41285107
PMCPMC13344643

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.